Please Wait...

Marieke Cajal

Translation skills

Main profile

Marieke Cajal, Ph.D.
Research Development Director, Bioclinica Research

Dr. Marieke Cajal is the Research Development Director at Bioclinica Research part of a leading research site network in Neurodegenerative Diseases.

Dr. Cajal began working as an academic researcher in 2008, and has since expanded her experience to all phases of clinical trials within numerous therapeutic areas.

Since joining Compass Research in 2015 (acquired by Bioclinica),, she has successfully led patient recruitment in Central Nervous System trials employing a community outreach program to raise awareness of disease and clinical trials. She maintains strong relations with sponsors, physicians, healthcare organizations, and patient advocacy groups.

Dr. Cajal earned a doctorate in Neurosciences from Sorbonne Paris Cité while conducting research on brain development for the French National Centre for Scientific Research. Additionally she has a Master’s in Genetics from Paris Diderot University and a Bachelor’s from Evry University. Dr. Cajal is a member of The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART).

Blogs

Considering the large number of individuals affected by Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), you might expect fast enrollment into clinical trials. The reality is quite different. Sponsors of clinical trials face several obstacles: 1) Patients are underdiagnosed. 2) Patients have a limited knowledge of clinical trials and some misconceptions.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (Yesterday)
#Pharma & CROs: Ck it out! Enterprise tools for site payments automation & reconciliation. https://t.co/LFri5Kv0WC
bioclinica (Yesterday)
Can having a geographically diverse network of high performing sites mean fewer sites are needed in a trial? Can ha… https://t.co/tZYvWrNzHg
bioclinica (Yesterday)
Confidence is a good thing ─ especially in the clinical supply chain for global clinical trials. Here’s how accurat… https://t.co/70VwXCwuWw
bioclinica (2 days ago)
#Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most… https://t.co/3YNpB9hTXs
bioclinica (5 days ago)
Announcing our new Chief of Staff @bioclinica Adrienne Rossi! Also welcoming President Bioclinica Site Network Eliz… https://t.co/toB9yk534k
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen